To clarify the histopathological progression of invasive tumors in the pituitary pars distalis due to estrogen, female Fischer 344 (F344) rats were treated subcutaneously with 5 mg/animal of estradiol dipropionate (ED) once every 2 wk for 13 wk. The animals were killed serially at 2-wk intervals during the investigation. The pituitaries with surrounding tissues were examined light microscopically. At week 7, pituitary cells showed proliferation and atypia with formation of blood-filled spaces. Lesions with these characteristics were diagnosed as adenomas. At week 9 or later, neoplastic cells exhibited extensive proliferation and infiltration into the surrounding tissues, suggesting development of carcinoma. Both proliferating cell nuclear antigen (PCNA) and 5-bromo-2'-deoxyuridine (BrdU) labeling index, markers of cell proliferation, were significantly increased in animals with adenoma or carcinoma. To detect sequential changes in pituitary weight, its signal intensity was periodically monitored in identical rats by using magnetic resonance (MR) imaging. The estimated pituitary weights revealed by MR imaging were comparable to the tumor weights obtained from rats at scheduled sacrifices. These results indicate that ED possesses the potential to cause carcinoma in rat pituitary and MR imaging is an effective tool for estimating the pituitary weight.
Atienza DM, Vigersky RJ, Lack EE, Carriaga M., Rusnock EJ, Tsou E., Carrone F., Kattah JG, and Sausville EA (1991). Prolactin-producing pituitary carcinoma with pulmonary metastasis. Cancer68: 1605-1610.
2.
Clifton KH and Meyer RK (1956). Mechanism of anterior pituitary tumor induction by estrogen. Anat. Rec. 125: 65-81.
3.
Doniach I. (1992). Pituitary carcinoma. Clin. Endocrinol . 37: 194-195.
4.
Fujimoto M., Yoshino E., Hirakawa K.Chihara K., and Ibata Y. (1987). Studies on estrogen induced pituitary tumor in the rat with special reference to the relationship of the tuberoinfundibular dopamine neuron system. J. Neurooncol. 5: 151-159.
5.
Geran RI, Greenberg NH, Macdonald MM, Schumacher AM, and Abbott BJ (1972). Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep. 3: 51-52.
6.
Goodman DG, Ward JM, and Squire RA (1979). Neoplastic and nonneoplastic lesions in aging F344 rat. Toxicol. Appl. Pharmacol. 48: 237-248.
7.
Haseman JK, Huff J., and Boorman GA (1984). Use of historical control data in carcinogenicity studies in rodents. Toxicol. Pathol. 12: 126-135.
8.
Hosokawa S., Fukuta T., Imai T., Sonoda J., Aoki T., Hayakawa K., Motooka S., and Nakanowatari J. (1993). Pituitary carcinoma of pars distalis as a common neoplasm in Fischer-344 rats. Toxicol. Pathol. 21: 283-287.
9.
Ito A. (1976). Pituitary tumors. Animal model: Pituitary tumors in rats. Animal model of human disease. Am. J. Pathol. 83: 423-426.
10.
Iwata H., Hirouchi Y., Koide Y., Yamakawa S., Kobayashi K., Yamamoto T., Kobayashi H., Inoue H., and Enomoto M. (1991). Historical control data of non-neoplastic and neoplastic lesions in F344/DuCrj rats. J. Toxicol. Pathol . 4: 1-24.
King AB (1951). The diagnosis of carcinoma of the pituitary gland . Johns Hopkins Hosp. Bull. 89: 339-353.
13.
Kovacs K., Horvath E., and Asa SL (1985). Classification and pathology of pituitary tumors . Neurosurgery1: 838.
14.
Lloyd RV (1983). Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am. J. Pathol. 113: 198-206.
15.
Lloyd RV (1990). Tumors of pituitary gland. In: Pathology of Tumors in Laboratory Animals, Vol. 1, Tumors of the Rat, 2nd ed., V Turusov and U Mohr (eds). Oxford University Press, Oxford, United Kingdom, pp. 499-537.
16.
Long MA and Colquhoun IR (1994). Case report: Multiple intracranial metastases from a prolactin-secreting pituitary tumor. Clin. Radiol. 49: 356-358.
17.
MacKenzie WF and Boorman GA (1990). Pituitary gland. In: Pathology of Fischer Rat, GA Boorman , SL Eustis, MR Elwell , CAJ Montgonery, and WF MacKenzie (eds). Academic Press , San Diego, California, pp. 485-500.
18.
Maekawa A., Kurokawa Y., Takahashi M., Kokubo T., Ogui T., Onodera H., Tanigawa H., Ohno Y., Furukawa F., and Hayashi Y. (1983). Spontaneous tumors in F344/DuCrj rats. Jpn. J. Cancer Res. (Gann)74: 365-372.
19.
Magnusson G. , Majeed SK, and Gopinath C. (1979). Infiltrating pituitary neoplasia in the rat. Lab. Anim. 13: 111-113.
20.
Maita K., Hirano M., Harada T., Mitumori K., Yoshida A., Takahashi K., Nakashima N., Kitazawa T., Enomoto A., Inui K., and Shirasu Y. (1987). Spontaneous tumors in F344/DuCrj rats from 12 control groups of chronic and oncogenicity studies. J. Toxicol. Sci. 12: 111-126.
21.
Matuno A., Ohsugi Y., Utsunomiya H., Takekoshi S., Sanno N., Osamura RY, Watanabe K., Teramoto A., and Kirino T. (1995). Changes in the ultrastructual distribution of prolactin and growth hormone mRNAs in pituitary cells of female rats after estrogen and bromocriptine treatment, studied using in situ hybridization with biotinylated oligonucleotide probes. Histochem. Cell Biol. 104: 37-45.
22.
Mitumori K. (1989). Spontaneous tumors of the pituitary and adrenal gland in rats and mice. J. Toxicol. Pathol. 2: 97-109 (in Japanese with English summary).
23.
Osamura RY (1996). Pituitary tumors induced by estrogen, rat. In: Monographs on Pathology of Laboratory Animal, TC Jones, CC Capen , and U Mohr (eds). ILSI Press, Washington, D.C., pp. 90-94.
24.
Osamura RY and Watanabe K. (1986). Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and effects of bromocriptine. Acta Pathol. Jpn. 36: 1131-1137.
25.
Petterson T. , MacFarlane IA, MacKenzie JM, and Shaw MDM (1992). Prolactin secreting pituitary carcinoma. J. Neurol. Neurosurg. Psychiatry55: 1205-1206.
26.
Popovice EA , Vattuane JR, Siu KH, Busmanis I., Pullar MJ, and Dowling J. (1991). Malignant prolactinoma . Neurosurgery29: 127-130.
27.
Powers RD and Winkler JK (1977). Pituitary carcinoma with extracranial metastasis in a cow. Vet. Pathol. 14: 524-526.
28.
Schechter J. , Ahmad N., Elias K., and Weiner R. (1987). Estrogen-induced tumors: Changes in the vasculature in two strains of rat. Am. J. Anat . 179: 315-323.
29.
Scheithaner BW , Kovacs KT, Laws ER, and Randall RV (1986). Pathology of invasive pituitary tumors with special reference to functional classification. J. Neurosurg. 65: 733-744.
30.
Stefaneanu L. and Kovacs K. (1994). Changes in structure and function of the pituitary . In: Pathobiology of the Aging Rat, Vol. 2, U Mohr, DL Dungworth, and CC Capen (eds). ILSI Press, Washington, D.C., pp. 173-191.
31.
Treip CS (1983). The regression of oestradiol-induced pituitary tumors in the rat. J. Pathol. 141: 29-40.
32.
van Nesselrooij JHJ , Szeverenyi NM, Tillapaugh-Fay GW, and Hendriksen GJ (1990). Gadolinium-DTPA-enhanced and digitally subtracted magnetic resonance imaging of estrogen-induced pituitary lesions in rats: Correlation with pituitary anatomy. Magn. Re-son. Imaging8: 525-533.
33.
van Nesselrooij JHJ , Bruijntjes JP, van Garderen-Hoetmer A., Tillapaugh-Fay GM and Feron VJ (1991). Magnetic resonance imaging compared with hormonal effects and histopathology of estrogen-induced pituitary lesions in the rat . Carcinogenesis12: 289-297.
34.
van Nesselrooij JHJ , Hendriksen Fgj, Feron VJ and Bosland MC (1992). Pathogenesis of blood-filled cavities in estrogen-induced anterior pituitary tumors in male Sprague-Dawley rats. Toxicol. Pathol. 20: 71-80.
35.
van Nesselrooij JHJ , Szeverenyi NM, Ritter-Hrncirik C., Tillapaugh-Fay GM, and Feron VJ (1992). Rat pituitary changes observed with magnetic resonance imaging following removal of estrogen stimulus: Correlation with histopathology and immunohistology. Carcinogenesis13: 277-282.
36.
Wikland J., Wertz N., and Gorski J. (1981). A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology109: 1700-1707.
37.
Wood GS and Warnke R. (1981). Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J. Histochem. Cytochem. 29: 1196-1120.
38.
Yokoro K. and Ito A. (1981). Experimental pituitary tumors. In: Hormone Related Tumors, H Nagasawa and K Abe (eds). Japan Scientific Societies Press, Tokyo, pp. 3-21.
